JOMDD, founded in 2012 and based in Japan, commercializes innovative medical technologies.
AVNeo is the first commercialized product. It allows a cardiac surgeon to reconstruct a diseased aortic valve using an autologous pericardium. AVNeo also known as the “Ozaki” procedure restores normal physiologic flow conditions allowing a patient to keep an active lifestyle. AVNeo is being performed in over 6000 cases in over 30 countries across the globe and has over 125 publications.
JOMDD is also partnering with Cardio Flow Design, Inc which develops blood flow imaging, an advanced research product, into an essential and practical tool and the de facto standard for cardiology and cardiovascular surgery.